Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Hetero Research Foundation
Hetero Research Foundation Hetero Drugs Limited

Hetero Research Foundation patents

Recent patent applications related to Hetero Research Foundation. Hetero Research Foundation is listed as an Agent/Assignee. Note: Hetero Research Foundation may have other listings under different names/spellings. We're not affiliated with Hetero Research Foundation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | Hetero Research Foundation-related inventors

Date Hetero Research Foundation patents (updated weekly) - BOOKMARK this page
11/23/17Process for the preparation of intermediate of dolutegravir
10/26/17Parenteral compositions of bendamustine
09/28/17Crystalline form of eltrombopag free acid
05/11/17Novel betulinic proline imidazole derivatives as hiv inhibitors
05/11/17Novel betulinic proline imidazole derivatives as hiv inhibitors
05/04/17Extended release compositions of carvedilol phosphate
03/30/17Process for pomalidomide
03/02/17Polymorphs of lomitapide and its salts
02/23/17Process for abiraterone acetate
02/02/17Process for cabazitaxel
01/26/17Pharmaceutical compositions of trametinib
01/12/17Pharmaceutical compositions of asenapine
01/12/17C-3 novel triterpenone with c-28 reverse amide derivatives as hiv inhibitors
10/27/16Parenteral compositions of bendamustine
09/01/16Process for regorafenib
07/28/16Pharmaceutical compositions of roflumilast and process for preparation thereof
06/30/16Compositions of eltrombopag
11/26/15Pharmaceutical compositions of linezolid
11/26/15Novel betulinic acid proline derivatives as hiv inhibitors
10/15/15Linagliptin solid dispersion
10/15/15Novel polymorphs of azilsartan
09/10/15Process for pralatrexate
09/03/15Solid oral compositions of tolvaptan
08/13/15Pharmaceutical formulations of rufinamide
07/02/15Rufinamide solid dispersion
07/02/15Stable compositions of fesoterodine
07/02/15Process for rilpivirine using novel intermediate
07/02/15Novel polymorphs of azilsartan medoxomil
05/21/15Solid oral compositions of silodosin
05/21/15Elvitegravir solid dispersion
05/14/15Process for sorafenib tosylate polymorph iii
04/30/15Novel betulinic acid derivatives as hiv inhibitors
03/19/15Crystalline hydrochloride salt of darunavir
03/19/15Amorphous form of lopinavir and ritonavir mixture
02/12/15Ritonavir compositions
01/22/15Novel polymorphs of fosamprenavir calcium
10/23/14Fast release solid oral compositions of entecavir
08/21/14Process for the resolution of omeprazole
08/14/14Process for rilpivirine
07/17/14Polymorphs of darunavir
05/01/14Process for bendamustine hydrochloride
04/24/14Process for febuxostat
04/17/14Process for fosaprepitant
12/19/13Pharmaceutical compositions of maraviroc and process for the preparation thereof
10/17/13Extended release compositions of quetiapine
09/26/13Novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
09/19/13Novel polymorph of nilotinib hydrochloride
09/19/13Process for the preparation of pazopanib using novel intermediate
09/12/13Novel polymorphs of pitavastatin calcium
08/29/13Oral pharmaceutical composition of duloxetine
08/01/13Darunavir compositions
07/25/13Novel polymorphs of febuxostat
07/25/13Process for preparing tolvaptan intermediates
07/25/13Process for olmesartan medoxomil
07/11/13Process for cinacalcet hydrochloride
05/30/13Salts of raltegravir
04/18/13Process for etravirine intermediate and polymorphs of etravirine
03/21/13Crystalline hydrochloride salt of darunavir
01/10/13Stable pharmaceutical composition of imatinib
11/15/12Amorphous darunavir
09/13/12Process for preparing efavirenz polymorph
09/06/12Bioequivalent formulation of efavirenz
08/23/12Process for the resolution of omeprazole
08/02/12Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
05/03/12Pharmaceutical compositions of valsartan
Patent Packs
03/29/12Solid oral dosage forms of lamivudine
02/09/12Novel polymorphs of saquinavir
01/19/12Novel polymorph of atazanavir sulfate
12/22/11Polymorphs of darunavir
12/15/11Novel polymorphs of sunitinib malate
12/01/11Novel polymorphs of lopinavir
10/27/11Polymorphs of zolmitriptan
10/06/11Optical resolution of substituted 1, 3-oxathiolane nucleosides
09/29/11Process for preparation of valsartan intermediate
09/01/11Novel polymorph of moxifloxacin hydrochloride
09/01/11Optical purification of esomeprazole
06/09/11Process for preparing lamivudine polymorph form
03/03/11Process for eprosartan intermediate
01/20/11Lupeol-type triterpene derivatives as antivirals
08/19/10Process for preparation of candesartan cilexetil
Patent Packs
09/08/11Pharmaceutically acceptable salts of novel betulinic acid derivatives

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Hetero Research Foundation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Hetero Research Foundation with additional patents listed. Browse our Agent directory for other possible listings. Page by